fosrenol 1000 mg žuvacie tablety
shire pharmaceutical contracts ltd. - hydrát uhličitanu lantanitého - 87 - varia i
fosrenol 1000 mg perorálny prášok
shire pharmaceutical contracts ltd. - hydrát uhličitanu lantanitého - 87 - varia i
fosrenol 750 mg perorálny prášok
shire pharmaceutical contracts ltd. - hydrát uhličitanu lantanitého - 87 - varia i
dysport 300 u
ipsen pharma, francúzsko - botulotoxín - 63 - myorelaxantia
sativex orálny roztokový sprej
jazz pharmaceuticals ireland ltd, Írsko - kanabinoidy - 63 - myorelaxantia
sarclisa
sanofi winthrop industrie - isatuximab - viacnásobný myelóm - antineoplastické činidlá - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
sirdalud 4 mg
sandoz pharmaceuticals d.d., slovinsko - tizanidín - 63 - myorelaxantia
oxytocin ferring-léčiva 5 iu
ferring-léčiva, a.s., Česká republika - oxytocín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
oxytocin ferring-léčiva 2 iu
ferring-léčiva, a.s., Česká republika - oxytocín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
citalec 10 zentiva
zentiva a.s., slovensko - citalopram - 30 - antidepressiva